Peter Wilden
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
Peter Wilden currently works at Schlumberger GmbH, as Vice Chairman-Supervisory Board from 2014, PolyPeptide Laboratories Holding (PPL) AB, as Chairman, PolyPeptide Group AG, as Chairman from 2023, Project HOPE-The-People-To-People HealthFoundation, Inc., as Director from 2012, Ferring Laboratories Ltd., as Director from 2004, Nesos Vermögensverwaltung GmbH, as Managing Director, and Ferring GmbH, as Member-Supervisory Board.
Dr. Wilden also formerly worked at Ferring International Center SA, as Executive Chairman from 2002 to 2023, Lonza Group AG, as Director from 2010 to 2014, Aureum Realwert AG, as Director from 1999 to 2002, Ferring BV, as Director-Group Finance from 1995 to 2000, Trizell Holding SA, as Director from 2014 to 2021, Ferring Pharmaceuticals A, as Chief Financial Officer & Executive Vice President from 2013 to 2017, Krupp Mak Maschinenbau GmbH, as Management Assistant in 1988, Kiel Institute for the World Economy, as Scientific Assistant-Information Technology Group in 1986, and FERRING Arzneimittel GmbH (Germany), as VP-Finance, Accounting & Technical Operations from 1993 to 1996.
Dr. Wilden received his doctorate degree in 1991 from the University of Kiel and Masters Business Admin degree in 1986 from the University of Kiel.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
POLYPEPTIDE GROUP AG 0,13 % | 31/12/2025 | 42 179 ( 0,13 % ) | 2 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SCHLUMBERGER AG | Directeur/Membre du Conseil | 11/09/2014 |
| POLYPEPTIDE GROUP AG | Président | 01/04/2021 |
Ferring GmbH
Ferring GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Nesos Vermögensverwaltung GmbH
Nesos Vermögensverwaltung GmbH Investment ManagersFinance Provides asset management services | Directeur Général | - |
PolyPeptide Laboratories Holding (PPL) AB
PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance Functions as an investment holding company | Président | - |
Ferring Laboratories Ltd.
Ferring Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Develops. manufactures and markets pharmaceutical products | Directeur/Membre du Conseil | 01/07/2004 |
Project HOPE-The-People-To-People HealthFoundation, Inc.
Project HOPE-The-People-To-People HealthFoundation, Inc. Medical/Nursing ServicesHealth Services Provides solutions to health problems | Directeur/Membre du Conseil | 01/01/2012 |
| Sociétés | Poste | Fin |
|---|---|---|
Ferring International Center SA
Ferring International Center SA Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics | Président | 01/08/2023 |
Trizell Holding SA | Directeur/Membre du Conseil | 01/06/2021 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 17 |
|---|---|
Lonza Group AG
Lonza Group AG BiotechnologyHealth Technology Develops and manufactures, biologics, biopharmaceuticals, small molecules & health ingredients | Health Technology |
Schlumberger GmbH /Austria/
Schlumberger GmbH /Austria/ Beverages: AlcoholicConsumer Non-Durables Manufactures and distributes sparkling wine, spirits and liqueurs | Consumer Non-Durables |
Aureum Realwert AG
Aureum Realwert AG Financial ConglomeratesFinance Engages in the acquisition, administration, and sale of financial assets such as investments in other companies | Finance |
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Specializes in the development, production and marketing of pharmaceutical products | Health Technology |
University of Kiel
University of Kiel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Project HOPE-The-People-To-People HealthFoundation, Inc.
Project HOPE-The-People-To-People HealthFoundation, Inc. Medical/Nursing ServicesHealth Services Provides solutions to health problems | Health Services |
Ferring International Center SA
Ferring International Center SA Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics | Health Technology |
Ferring BV
Ferring BV BiotechnologyHealth Technology Operates as a biopharmaceutical organization that develops reproductive, maternal health, gastroenterology and urology medicine | Health Technology |
Krupp Mak Maschinenbau GmbH | |
Ferring GmbH
Ferring GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
PolyPeptide Laboratories Holding (PPL) AB
PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Kiel Institute for the World Economy
Kiel Institute for the World Economy Investment ManagersFinance Provides investment research | Finance |
Ferring Laboratories Ltd.
Ferring Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Develops. manufactures and markets pharmaceutical products | Health Technology |
FERRING Arzneimittel GmbH (Germany)
FERRING Arzneimittel GmbH (Germany) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Nesos Vermögensverwaltung GmbH
Nesos Vermögensverwaltung GmbH Investment ManagersFinance Provides asset management services | Finance |
PolyPeptide Group AG
PolyPeptide Group AG BiotechnologyHealth Technology Manufactures polypeptide and custom peptide synthesis | Health Technology |
Trizell Holding SA |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national